INTRODUCTION
Extended hepatectomy is performed for radical resection of hepatobiliary tract malignancies, but the mortality rate is not low. Hepatic failure greatly contributes to death after liver resection, and the pathophysiology involved is similar to that of sepsis [1] [2] [3] [4] [5] . Severe septic complications are associated with reduced phagocytic function of the reticuloendothelial system after massive hepatectomy [6] . Although two-thirds resection of the liver is not fatal in rodents, there is increased sensitivity to endotoxin in the early phase after hepatectomy.
Furthermore, intravenous injection of a sublethal dose of lipopolysaccharide (LPS)
postoperatively induces a high mortality [7] .
Active hexose correlated compound (AHCC) is an extract from mycelia of Lentinula edodes. This is a mushroom of the basidiomycete family that is cultured in liquid medium in a large tank. AHCC is one of the functional foods that are most frequently used in cancer patients in clinical practice [8] .
Animal liver injury models can be caused by various insults, such as ischemia-reperfusion, partial hepatectomy, and endotoxin shock. Using these models, we have previously reported that drugs showing liver-protective effects inhibit induction of inducible nitric oxide synthase (iNOS) and nitric oxide (NO) production [9] [10] [11] [12] [13] . These drugs also decrease production of various inflammatory mediators, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and cytokine-induced neutrophil chemoattractant (CINC)-1 (human IL-8 analogue). Furthermore, by using primary cultures of rat hepatocytes, we found that AHCC, its sugar fraction, and one of its components (adenosine) inhibited nuclear factor (NF)-κB activation, resulting in inhibition of iNOS induction and NO production [14] [15] [16] . These reports suggest that AHCC has potential effects on prevention of various liver injuries.
However, few studies have reported that AHCC markedly enhances the survival rate in animal models of postoperative liver failure, with greater than 90% mortality. In this study, we investigated whether treatment of AHCC improves the survival rate in a rat model of endotoxin-induced liver injury after partial hepatectomy. Additionally, if the survival rate is improved, we aimed to determine whether AHCC affects expression of various inflammatory mediators, including iNOS and TNF-α.
MATERIALS AND METHODS

Materials:
The manufacturing process of AHCC is as follows: When basidiomycetes are cultured in a liquid medium, they proliferate and form globular fungal bodies rather than carpophores [17] . AHCC is produced using these bodies of mycelia of basidiomycetes and contains components of the medium that are modified by the mycelia-produced diverse enzymes. In the actual manufacturing procedure of AHCC, the mycelia of the edible shiitake are subjected to a liquid culture (15,000-L tank). After fermentation, AHCC is produced through manufacturing processes, which include separation, concentration, sterilization, and freeze-drying [18] . AHCC is certified under the "Healthy Do" system (Hokkaido Food Functionality Labelling system) in which the Hokkaido Government in Japan recognizes the conduct of scientific research on the health effects of product components.
Lipopolysaccharide (LPS, Escherichia coli 0111: B4) was purchased from Sigma-Aldrich (St.
Louis, MO, USA).
Experimental design: Male Sprague-Dawley rats (6 weeks old; weighing 200 g) were obtained from Charles River (Tokyo, Japan). The rats were kept at 22°C under a 12-h light-dark cycle and received food and water ad libitum. Rats were randomly divided into control (normal diet rat), AHCC, 70% of partial hepatectomy and lipopolysaccharide (PH/LPS), and PH/LPS + AHCC groups. A normal diet with or without 2% (w/w) AHCC (Amino Up Chemical Co. Ltd., Sapporo, Japan) was administered orally with free access 10 days before 70% hepatectomy, which was followed by sham operation (control and AHCC groups). Rats were anesthetized with intraperitoneal injection of pentobarbital, prior to undergoing 70% hepatectomy as reported previously [9, 10] . After 48 h of surgery, LPS (250 µg/kg) was injected into the penile vein (PH/LPS and PH/LPS + AHCC groups). Survival was checked during 72 h after injection of LPS. Blood and liver samples were obtained from individual rats at 1, 3, and 6 h after LPS treatment.
All animal experiments were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals of the National Institutes of Health. Experiments were approved by the Animal Care Committee of Kansai Medical University.
Biochemical analysis in serum:
Blood samples were collected at 1, 3, and 6 h after LPS injection. Serum levels of aspartate transaminase (AST) and alanine transaminase (ALT) were determined using commercial kits (Wako Pure Chemical, Osaka, Japan). TNF-α, CINC-1, IL-6, and IL-10 levels were measured in serum using commercial kits (R&D Systems, Minneapolis, MN, USA). The sum of serum nitrite and nitrate (NO 2 − and NO 3 − , respectively; stable metabolites of NO) was measured using the Griess reagent method using a commercial kit (Roche Diagnostics, Mannheim, Germany) [19] .
Histopathological analysis: Excised liver specimens that were collected 6 h after LPS treatment were fixed in 10% formalin and embedded in paraffin. Sections (3-5 µm) were cut and stained with hematoxylin and eosin. Apoptotic bodies were detected by terminal deoxynucleotidyl transferase-mediated dUTP-digoxigenin nick-end labeling (TUNEL) staining using an apoptosis detection kit (Medical and Biological Laboratories Co., Nagoya, Japan). The number of TUNEL-positive cells per square millimeter was counted.
TUNEL-positive cells were quantified in a manner that was blinded to the treatment arm. All glycerol, 2% sodium dodecyl sulfate, and 1% 2-mercaptoethanol), subjected to a 7.5% gel, and electroblotted onto a polyvinylidene-difluoride membrane (Bio-Rad, Hercules, CA, USA). Immunostaining was performed using primary antibodies against mouse iNOS (Thermo Scientific, Rockford, IL, USA) and rat β-tubulin (internal control; Clone TUB2.1;
Sigma Chemical Co., St. Louis, MO, USA), followed by visualization with an enhanced chemiluminescence blotting detection reagent (GE Healthcare Biosciences Corp., Piscataway, NJ, USA). The bands corresponding to iNOS protein were quantitated by densitometry (ImageJ software) and normalized to β-tubulin.
Real-time RT-PCR:
Total RNA was extracted from homogenized liver in TRIzol (Gibco BRL, USA) reagent using the guanidinium-phenol-chloroform method [20] . For strand-specific RT-PCR analysis, complementary DNAs were synthesized from total RNA with strand-specific primers, and step-down PCR was performed as previously described [21] . For iNOS (257 bp), TNF-α (275 bp), IL-6 (286 bp), IL-1β (321 bp), CINC-1 (231 bp), IL-10 (245 bp), and elongation factor-1α (EF; internal control; 332 bp) mRNAs, an oligo (dT) primer was used for the RT reaction. The primer sets that were used for PCR are shown in Table 1 . These mRNA levels were measured by real-time PCR using the Rotor-Gene Q 2plex HRM (Qiagen, Tokyo, Japan). The Rotor-Gene SYBR Green PCR Kit (Qiagen) was included in the reaction mixture, and the following touchdown protocol was applied: 1 cycle at 95°C for 5 min, and 45 cycles at 95°C for 5 s and 60°C for 10 s. Each mRNA was detected by normalizing the copy number by that of EF. The complementary DNAs for the rat iNOS mRNA were deposited in the DNA Data Bank of Japan/European Bioinformatics Institute/GenBank under the accession number AB250951.
Electrophoretic mobility shift assay: Nuclear extracts were prepared from frozen liver at −80ºC [22] with a minor modification. Liver sections (0.05 g) were homogenized with a Dounce homogenizer in 1 mL of buffer A (10 mM HEPES-KOH, pH 7.9; containing 10 mM KCl, 1.5 mM MgCl 2 , 1 mM dithiothreitol, 1 mM PMSF, and 5 µg/mL aprotinin) and allowed to swell for 15 min. The homogenates were then centrifuged (1100 × g for 5 min). The pellet was suspended in 1 mL of lysis buffer (buffer A supplemented with 0.1% Triton X-100), allowed to stand for 10 min, and centrifuged (1100 × g for 10 min). The nuclear pellet was suspended in 200 µL of nuclear extraction buffer (20 mM HEPES-KOH, pH 7.9; containing 0.42 M NaCl, 1.5 mM MgCl 2 , 1 mM dithiothreitol, 1 mM PMSF, 5 µg/mL aprotinin, 0.2 mM EDTA, and 25% [vol/vol] glycerol), incubated for 30 min, and centrifuged (16,500 × g for 20 min). Binding reactions were performed by incubating the nuclear extract (5 µg protein) in reaction buffer (20 mM HEPES-KOH, pH 7.9; containing 1 mM EDTA, 60 mM KCl, 10% glycerol, and 1 µg of poly[dI-dC]) with the probe (40,000 dpm) for 20 min at room temperature. Products were electrophoresed on a 4.8% polyacrylamide gel in high ionic strength buffer, and dried gels were analyzed by autoradiography. An NF-κB consensus oligonucleotide (5'-AGTTGAG GGGA-CTTTCCCAGGC) from the mouse immunoglobulin light chain was purchased (Promega, Madison, WI, USA) and labeled with [γ-32 P]-adenosine triphosphate and T4 polynucleotide kinase. Protein was measured using the method of Bradford [23] . The bands corresponding to NF-κB were quantitated by densitometry (ImageJ software).
Statistical analysis:
All data are expressed as the mean ± SE. Differences between groups and the rate of survival were identified by a two-way ANOVA and the log-rank test, respectively. P < 0.05 was considered to be statistically significant. (cDNA) to mRNA. iNOS, inducible nitric oxide synthase; TNF-α, tumor necrosis factor-α; CINC-1, cytokine-induced neutrophil chemoattractant-1; IL-6, interleukin-6; IL-1β, interleukin-1β; EF, elongation factor-1α. F/R, forward/reverse.
RESULTS
AHCC enhanced the survival of rats with liver injury
More than 90% of rats died within 72 h after treatment of 70% hepatectomy and LPS (PH/LPS). Pretreatment of normal diet with 2% AHCC in PH/LPS-treated rats enhanced the survival rate by 70% (Fig. 1) . Serum levels of transaminases (AST and ALT), which are the markers of hepatocellular damage, were reduced with treatment of AHCC (Fig. 2) . 
AHCC reduced the appearance of pathological changes
Histological alteration of the liver in PH/LPS rats was characterized by inflammatory cell infiltration, hemorrhagic changes, and focal necrosis in the midzone and periportal regions. Focal hepatocyte necrosis with hemorrhagic changes, ballooning degeneration, and inflammatory cell infiltration were observed in the liver 6 h after PH/LPS (Fig. 3A) , and AHCC prevented these pathological changes (Fig. 3B) . PH/LPS treatment dramatically increased apoptosis of hepatocytes in the liver (Fig. 3C) . AHCC markedly reduced apoptosis in hepatocytes and decreased the apoptotic index of the liver (Fig. 3D and 3E ). In rats that were treated with AHCC alone (without PH/LPS), the liver showed normal hepatic histology (data not shown). 
AHCC affected the expression of iNOS and cytokines in the liver
During endotoxemia, excess production of NO caused by iNOS has a crucial role in hepatic dysfunction. PH/LPS treatment increased iNOS mRNA levels and AHCC inhibited its expression in the liver (Fig. 4A ). There was a negligible expression of iNOS mRNA in the normal and AHCC alone (without PH/LPS) rat groups and there was no significant difference between the two groups (data not shown). Western blotting showed that PH/LPS treatment increased iNOS protein expression at 3 h and AHCC reduced its expression (Fig. 4B) . In support of these observations, serum levels of nitrite and nitrate, which are stable metabolites of NO, increased after PH/LPS treatment at 6 h. AHCC inhibited this increase in nitrite and nitrate levels (Fig. 4C) . Real-time RT-PCR analysis showed that PH/LPS treatment increased mRNA expression of TNF-α, CINC-1, IL-6, and IL-1β. AHCC decreased mRNA expression of TNF-α, CINC-1, and IL-6 (Fig. 5A , 5B and 5C, respectively), but had no effect on IL-1β mRNA expression (Fig. 5D) . In contrast, AHCC increased anti-inflammatory IL-10 mRNA expression (Fig. 5E) , whereas PH/LPS treatment had no effect on IL-10 mRNA expression. There was a negligible expression of TNF-α, CINC-1, IL-6, IL-1β and IL-10 mRNA in the normal and AHCC alone (without PH/LPS) rat groups (data not shown). In serum analysis, AHCC increased IL-10 levels (Fig. 6D) , but there were no significant differences in other serum cytokines between the two groups (Fig. 6A, 6B, and 6C) . 
AHCC inhibited the activation of NF-kB in the liver
Recent evidence has indicated that NF-kB is involved in the transcriptional activation of a variety of inflammatory genes, such as iNOS, TNF-α, and CINC-1. We examined the effect of AHCC on NF-kB activation (its nuclear translocation and DNA binding) in the liver. The electrophoretic mobility shift assay with hepatic nuclear extracts showed that PH/LPS treatment stimulated activation of NF-kB at 3 h and AHCC reduced the levels of NF-kB activation (Fig. 7) . 
DISCUSSION
In our preliminary study, a normal diet with 1% AHCC demonstrated a tendency to increase the survival rate of rats, but this was not significant (Tanaka and Nakatake, unpublished observation). In the current study, we found that oral intake of a normal diet with 2% AHCC before treatment of PH/LPS attenuated the increase in AST and ALT levels (Fig. 2) , and reduced the appearance of pathological changes, including apoptosis (Fig. 3) . This led to marked improvement in the survival rate of rats (Fig. 1) .
AHCC is abundant in the α-glucan form of carbohydrates. The presence of α-1,4-glucan, in which the hydroxyl groups of C-2 and/or C-3 position are partially acylated, is particularly reported and is considered to be one of the active ingredients [18] . Based on a survey carried out by the Ministry of Health, Labor and Welfare research group in Japan, AHCC is the second most commonly used health food, followed by Agaricus, which is a fungus, among cancer patients in Japan [8] . AHCC is useful for treating various diseases, including hepatitis and cancer, as a complementary and alternative medicine [24] . We reported that AHCC improved the prognosis of patients with hepatocellular carcinoma postoperatively (a prospective cohort study) [25] . AHCC is effective for treating infectious and inflammatory 
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diseases, and is a cancer therapy [26] [27] [28] [29] [30] [31] [32] . The safety of AHCC has been supported by basic studies, including its interaction with drugs [33] [34] [35] . Results of a randomized, controlled trial on healthy volunteers strongly supported the safety of AHCC as a supplement in clinical practice [36] .
In this study, AHCC inhibited the expression of iNOS mRNA and its protein, leading to inhibition of NO production (Fig. 4A, 4B , and 4C). AHCC decreased mRNA expression of TNF-α, CINC-1, and IL-6 in the liver (Fig. 5A , 5B, and 5C). However, we did not find a reduction in serum TNF-α, CINC-1, and IL-6 levels. This finding was unexpected and the reasons currently remain unclear. AHCC enhanced IL-10 levels in the liver and serum (Figs.
5E and 6D). Accordingly, part of the protective effects of AHCC in our rat model of endotoxin-induced acute liver injury probably resulted from attenuation of iNOS, TNF-α, CINC-1, and IL-6, and enhancement of IL-10.
One of the earliest events after interaction of LPS with toll-like receptor 4 is activation of transcription factor NF-κB in cells, with its translocation from the cytoplasm to the nucleus and DNA binding [37] . Once activated, NF-κB induces transcriptional upregulation of various inflammatory mediators, such as iNOS, TNF-α, and CINC-1 [38] [39] [40] . The electrophoretic mobility shift assay with nuclear extracts from the liver showed that AHCC decreased activation of NF-κB induced by PH/LPS treatment (Fig. 7) . 
CONCLUSION
Disclosure of potential conflicts of interest:
The authors declare that they have no conflicts of interest.
Author's contributions: RN participated in the design of the study, data collection, statistical analysis, and drafting of the manuscript. YT and YU participated in supervision and provided advice when the manuscript was being drafted. HM assisted in data collection and analysis. MI, KM, and MK assisted in the design of the study. TO, MN and MKon provided advice regarding protocol development for the study and assisted in the design of the study.
Acknowledgments:
This work was supported in part by a Grant-in-Aid for Scientific
